首页|Nanotechnology-based Detection Strategies for Hypertension Biomarkers

Nanotechnology-based Detection Strategies for Hypertension Biomarkers

扫码查看
Hypertension significantly increases the risk of cardiovascular diseases and seriously affects people's health.The incidence of hypertension is rising rapidly in the world and hypertension has become a significant factor influencing the global average life expectancy.The diagnosis of hypertension is generally fulfilled by measuring diastolic and systolic blood pressure,but it is insufficient to differentiate essential hypertension from secondary hypertension,so it is crucial to identifying the cause of hypertension by detecting biomarkers in plasma.In clinical practice,five plasma biomarkers are utilized for diagnosing hypertension,and the detection tasks of a large number of cases have raised increasing demands for cost-effective,efficient,speedy,and diverse methods,which makes many traditional diagnostic technologies inadequate for meeting the needs of clinical diagnosis.The nanomaterial-based detection techniques have frequently attained the qualities of quick reaction,low cost,straightforward operation,high sensitivity,and strong specificity in recent years with the advancement of nanotechnology,so they have great potential for early and rapid diagnosis.In this review,we will introduce the characteristics and drawbacks of current clinical detection methods for hypertension screening,the principles and advancements of nanotechnology-based detection methods,as well as their potentials for clinical application.

HypertensionBiomarkerDiagnosisClinical detectionNanotechnology-based detection

WANG Zhichao、ZENG Yuan、WANG Yaling、CHEN Chunying

展开 >

Henan Institute of Advanced Technology,Zhengzhou University,Zhengzhou 450003,P.R.China

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology of China,Chinese Academy of Sciences(CAS),Beijing 100190,P.R.China

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Basic Research Program of ChinaNational Basic Research Program of ChinaStrategic Priority Research Program of Chinese Academy of SciencesChinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences

2230702882341044220278102022YFA16037012021YFA1200900XDB36000000CIFMS 2019-I2M-5-018

2024

高等学校化学研究(英文版)
吉林大学

高等学校化学研究(英文版)

CSTPCD
影响因子:0.871
ISSN:1005-9040
年,卷(期):2024.40(4)